 Association between expression of random gene sets and survival is evident in multiple cancer types and may be explained by sub-classificationYishai Shimoni PLOS Computational Biology, 2018, vol. 14, issue 2, 1-15 Abstract: One of the goals of cancer research is to identify a set of genes that cause or control disease progression. However, although multiple such gene sets were published, these are usually in very poor agreement with each other, and very few of the genes proved to be functional therapeutic targets. Furthermore, recent findings from a breast cancer gene-expression cohort showed that sets of genes selected randomly can be used to predict survival with a much higher probability than expected. These results imply that many of the genes identified in breast cancer gene expression analysis may not be causal of cancer progression, even though they can still be highly predictive of prognosis. We performed a similar analysis on all the cancer types available in the cancer genome atlas (TCGA), namely, estimating the predictive power of random gene sets for survival. Our work shows that most cancer types exhibit the property that random selections of genes are more predictive of survival than expected. In contrast to previous work, this property is not removed by using a proliferation signature, which implies that proliferation may not always be the confounder that drives this property. We suggest one possible solution in the form of data-driven sub-classification to reduce this property significantly. Our results suggest that the predictive power of random gene sets may be used to identify the existence of sub-classes in the data, and thus may allow better understanding of patient stratification. Furthermore, by reducing the observed bias this may allow more direct identification of biologically relevant, and potentially causal, genes.Author summary: Multiple gene sets have been published as predictive of cancer progression and metastasis in several cancer types. Although many of these sets proved to be highly predictive of survival, even gene sets for the same cancer (but from different data-sets or different analyses) exhibit very little overlap and to date did not provide functional therapeutic targets. Recent studies found that in breast cancer, even random gene sets can predict survival much better than would be expected, and on average are better than many published gene sets. Together, these results undermine the causal role of the published gene sets and their potential clinical implications. We show that random gene sets predict survival in many cancer types, and that this property no longer exists after splitting the data into subclasses based on data-driven clusters. This suggests that such sub-classification could increase the likelihood to identify causal genes that are potential therapeutic targets, and that this property can be used as an indication that there may be subclasses within the dataset. Date: 2018 Downloads: (external link) Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:plo:pcbi00:1006026 DOI: 10.1371/journal.pcbi.1006026 Access Statistics for this article More articles in PLOS Computational Biology from Public Library of Science |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.